{"id":46056,"date":"2022-07-12T12:02:46","date_gmt":"2022-07-12T10:02:46","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\/"},"modified":"2022-07-12T12:02:46","modified_gmt":"2022-07-12T10:02:46","slug":"global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\/","title":{"rendered":"Global Hematologic Malignancies Testing Market to Reach $11.68 Billion by 2032 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5624778\/global-hematologic-malignancies-testing-market?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=q54p53&amp;utm_campaign=1724500+-+Global+Hematologic+Malignancies+Testing+Market+to+Reach+%2411.68+Billion+by+2032&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Hematologic Malignancies Testing Market: Focus on Hematologic Malignancies Testing Product and Application, Supply Chain Analysis, and Country Analysis &#8211; Analysis and Forecast, 2022-2032&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220712005649\/en\/1510948\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220712005649\/en\/1510948\/21\/logo.jpg\"><\/a><\/p>\n<p>\n<strong>Hematologic Malignancies Testing Market: Industry Overview<\/strong>\n<\/p>\n<p>\nThe global hematologic malignancies testing market is projected to reach $11,680.1 million by 2032, growing from $2,606.5 million in 2021, at a CAGR of 14.23% during the forecast period 2022-2032. The global market for hematologic malignancies testing has grown significantly, owing to the rising demand for numerous biomarker-based molecular diagnostics.\n<\/p>\n<p>\nThe advancements have aided in enhancing the quality of life and decreasing treatment costs and time, driving the overall growth of the healthcare diagnostics market. Furthermore, the worldwide hematologic malignancies testing market is being driven by rising awareness and adoption of the precision diagnostic technique in both developed and developing countries.\n<\/p>\n<p>\n<strong>Market Lifecycle Stage<\/strong>\n<\/p>\n<p>\nHematologic malignancies are a type of cancer that starts in blood-forming tissue, such as the bone marrow or immune system cells. With an enhanced genomic review of cancer and developments in molecular diagnostic technology, genetic characterization has become increasingly important in the clinical evaluation of practically every kind of hematologic malignancy. In economically developed countries, hematological malignancies (blood cancers) are the fifth most prevalent cancer kind.\n<\/p>\n<p>\nThey&#8217;re generally divided into three groups based on whether cancer starts in the blood (leukemia), lymph nodes (Hodgkin&#8217;s lymphoma and non-Hodgkin&#8217;s lymphoma), or bone (osteosarcomas and myelomas). The global hematologic malignancies testing market is undergoing a significant change about the advancements that have already taken place and are currently invading the market space.\n<\/p>\n<p>\nAdditionally, with the emergence of advanced diagnostic technologies, there is immense potential for emerging submarkets such as the nucleic acid extraction market to continue fueling the overall hematologic malignancies testing market. Further, with highly opportunistic trends coming into play with the rapid incorporation of hematologic malignancies testing in the management of cancer in healthcare settings, there is immense potential for growth in this market.\n<\/p>\n<p>\n<strong>Market Segmentation<\/strong>\n<\/p>\n<p>\n<strong>by Platform<\/strong>\n<\/p>\n<ul>\n<li>\nPolymerase Chain Reaction (PCR)\n<\/li>\n<li>\nNext-Generation Sequencing (NGS)\n<\/li>\n<li>\nFluorescence In-Situ Hybridization (FISH)\n<\/li>\n<li>\nFlow Cytometry\n<\/li>\n<li>\nImmunohistochemistry (IHC)\n<\/li>\n<li>\nOther Platforms\n<\/li>\n<\/ul>\n<p>\n<strong>by Disease<\/strong>\n<\/p>\n<ul>\n<li>\nLeukemia\n<\/li>\n<li>\nLymphoma\n<\/li>\n<li>\nMultiple Myeloma\n<\/li>\n<li>\nMyeloproliferative Neoplasm\n<\/li>\n<li>\nMyelodysplastic Syndrome\n<\/li>\n<\/ul>\n<p>\n<strong>by Product<\/strong>\n<\/p>\n<ul>\n<li>\nKits\n<\/li>\n<li>\nServices\n<\/li>\n<\/ul>\n<p>\n<strong>by End User<\/strong>\n<\/p>\n<ul>\n<li>\nSpecialty Clinics and Hospitals\n<\/li>\n<li>\nDiagnostic Laboratories\n<\/li>\n<li>\nReference Laboratories\n<\/li>\n<li>\nResearch Institutions\n<\/li>\n<\/ul>\n<p>\n<strong>Demand &#8211; Drivers and Limitations<\/strong>\n<\/p>\n<p>\n<strong>Following are the demand drivers for the hematologic malignancies testing market:<\/strong>\n<\/p>\n<ul>\n<li>\nIncreasing Key Player Initiatives\n<\/li>\n<li>\nGrowing Funding in the Market for Hematologic Malignancies Testing\n<\/li>\n<\/ul>\n<p>\n<strong>The market is expected to face some limitations too due to the following challenges:<\/strong>\n<\/p>\n<ul>\n<li>\nLack of Qualified Professionals\n<\/li>\n<li>\nIssues Concerning the Analytical Validity of Cancer Genetic Testing\n<\/li>\n<\/ul>\n<p>\n<strong>Key Market Players and Competition Synopsis<\/strong>\n<\/p>\n<p>\nThe companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.\n<\/p>\n<p>\nSome prominent names established in this market are:\n<\/p>\n<ul>\n<li>\nAbbott.\n<\/li>\n<li>\nASURAGEN, INC.\n<\/li>\n<li>\nAdaptive Biotechnologies\n<\/li>\n<li>\nARUP Laboratories\n<\/li>\n<li>\nBio-Rad Laboratories, Inc.\n<\/li>\n<li>\nF. Hoffmann-La Roche Ltd\n<\/li>\n<li>\nIllumina, Inc.\n<\/li>\n<li>\nICON plc\n<\/li>\n<li>\nInvivoscribe, Inc.\n<\/li>\n<li>\nInvitae Corporation.\n<\/li>\n<li>\nLaboratory Corporation of America Holdings\n<\/li>\n<li>\nNeoGenomics Laboratories\n<\/li>\n<li>\nOHSU&#8217;s Knight Diagnostic Laboratories\n<\/li>\n<li>\nPrecipio\n<\/li>\n<li>\nQIAGEN N.V.\n<\/li>\n<li>\nQuest Diagnostics\n<\/li>\n<li>\nSysmex Corporation<\/p>\n<p>\n\u00a0\n<\/p>\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1 Market<\/strong>\n<\/p>\n<p>\n<strong>2 Market Dynamics<\/strong>\n<\/p>\n<p>\n2.1 Overview\n<\/p>\n<p>\n2.2 Impact Analysis\n<\/p>\n<p>\n2.3 Market Drivers\n<\/p>\n<p>\n2.3.1 Rising Incidence in Hematologic Malignancies\n<\/p>\n<p>\n2.3.1.1 New Cases\n<\/p>\n<p>\n2.3.1.2 Deaths\n<\/p>\n<p>\n2.3.2 Increasing Key Player Initiatives\n<\/p>\n<p>\n2.3.3 Growing Funding in the Market for Hematologic Malignancies Testing\n<\/p>\n<p>\n2.4 Market Restraints\n<\/p>\n<p>\n2.4.1 Lack of Qualified Professionals\n<\/p>\n<p>\n2.4.2 Issues Concerning the Analytical Validity of Cancer Genetic Testing\n<\/p>\n<p>\n2.5 Market Opportunities\n<\/p>\n<p>\n2.5.1 Increasing Research and Development Activities\n<\/p>\n<p>\n2.5.2 Technological Advancements in the Field of Hematologic Malignancies Testing\n<\/p>\n<p>\n2.6 Industry Analysis\n<\/p>\n<p>\n2.7 COVID-19&#8217;s Impact on Cancer Diagnostic Market\n<\/p>\n<p>\n2.8 Supply Chain Analysis\n<\/p>\n<p>\n2.8.1 Key Entities in Supply Chain\n<\/p>\n<p>\n2.9 Pricing Analysis\n<\/p>\n<p>\n<strong>3 Competitive Landscape<\/strong>\n<\/p>\n<p>\n3.1 Overview\n<\/p>\n<p>\n3.2 Synergistic Activities\n<\/p>\n<p>\n3.3 Product Launches\n<\/p>\n<p>\n3.4 Product Approvals\n<\/p>\n<p>\n3.5 Mergers and Acquisitions\n<\/p>\n<p>\n3.6 Other Business Activities\n<\/p>\n<p>\n3.7 Market Share Analysis (by Company), 2020 and 2021\n<\/p>\n<p>\n3.8 Growth-Share Analysis (by Platform)\n<\/p>\n<p>\n<strong>4 Products<\/strong>\n<\/p>\n<p>\n<strong>5 Platform<\/strong>\n<\/p>\n<p>\n<strong>6 Diseases<\/strong>\n<\/p>\n<p>\n<strong>7 End User<\/strong>\n<\/p>\n<p>\n<strong>8 Region<\/strong>\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5624778\/global-hematologic-malignancies-testing-market?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=q54p53&amp;utm_campaign=1724500+-+Global+Hematologic+Malignancies+Testing+Market+to+Reach+%2411.68+Billion+by+2032&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/u7hn8v<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#x70;&#x72;&#x65;&#x73;&#x73;&#x40;&#x72;&#101;&#115;&#101;&#97;&#114;&#99;&#104;&#97;&#110;&#100;&#109;arkets&#46;c&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;r&#x65;&#115;&#x73;&#x40;r&#x65;&#115;&#x65;&#x61;r&#x63;&#104;&#x61;&#x6e;d&#x6d;&#97;&#x72;&#x6b;e&#x74;&#115;&#x2e;&#x63;o&#x6d;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Hematologic Malignancies Testing Market: Focus on Hematologic Malignancies Testing Product and Application, Supply Chain Analysis, and Country Analysis &#8211; Analysis and Forecast, 2022-2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Hematologic Malignancies Testing Market: Industry Overview The global hematologic malignancies testing market is projected to reach $11,680.1 million by 2032, growing from &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46056","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Hematologic Malignancies Testing Market to Reach $11.68 Billion by 2032 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Hematologic Malignancies Testing Market to Reach $11.68 Billion by 2032 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Hematologic Malignancies Testing Market: Focus on Hematologic Malignancies Testing Product and Application, Supply Chain Analysis, and Country Analysis &#8211; Analysis and Forecast, 2022-2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Hematologic Malignancies Testing Market: Industry Overview The global hematologic malignancies testing market is projected to reach $11,680.1 million by 2032, growing from ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-12T10:02:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220712005649\/en\/1510948\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Hematologic Malignancies Testing Market to Reach $11.68 Billion by 2032 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-07-12T10:02:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\\\/\"},\"wordCount\":691,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220712005649\\\/en\\\/1510948\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\\\/\",\"name\":\"Global Hematologic Malignancies Testing Market to Reach $11.68 Billion by 2032 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220712005649\\\/en\\\/1510948\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-07-12T10:02:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220712005649\\\/en\\\/1510948\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220712005649\\\/en\\\/1510948\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Hematologic Malignancies Testing Market to Reach $11.68 Billion by 2032 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Hematologic Malignancies Testing Market to Reach $11.68 Billion by 2032 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Hematologic Malignancies Testing Market to Reach $11.68 Billion by 2032 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Hematologic Malignancies Testing Market: Focus on Hematologic Malignancies Testing Product and Application, Supply Chain Analysis, and Country Analysis &#8211; Analysis and Forecast, 2022-2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Hematologic Malignancies Testing Market: Industry Overview The global hematologic malignancies testing market is projected to reach $11,680.1 million by 2032, growing from ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-12T10:02:46+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220712005649\/en\/1510948\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Hematologic Malignancies Testing Market to Reach $11.68 Billion by 2032 &#8211; ResearchAndMarkets.com","datePublished":"2022-07-12T10:02:46+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\/"},"wordCount":691,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220712005649\/en\/1510948\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\/","name":"Global Hematologic Malignancies Testing Market to Reach $11.68 Billion by 2032 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220712005649\/en\/1510948\/21\/logo.jpg","datePublished":"2022-07-12T10:02:46+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220712005649\/en\/1510948\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220712005649\/en\/1510948\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-hematologic-malignancies-testing-market-to-reach-11-68-billion-by-2032-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Hematologic Malignancies Testing Market to Reach $11.68 Billion by 2032 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46056","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46056"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46056\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46056"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46056"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46056"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}